-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Spyre Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2014 to 2023.
- Spyre Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$13.6M, a 37.4% increase year-over-year.
- Spyre Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$21.6M, a 72.6% increase year-over-year.
- Spyre Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was -$96.5M, a 11728% decline from 2022.
- Spyre Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $830K.
- Spyre Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$11K, a 102% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)